This retrospective cohort study reported an association between GLP1RA use and a lower risk of acute asthma exacerbations in adolescents with overweight or obesity, suggesting a potential dual benefit for this population.

This cohort study investigates the association between glucagonlike peptide-1 receptor agonist use and the risk of acute asthma exacerbations among adolescents with overweight or obesity and asthma.